Cell and Gene Outsourcing

  1. Streamlining Viral Vector Development And Gene Therapy Manufacturing 7/19/2023

    Explore solutions for gene therapy production from experts, as they highlight the key features of a GMP manufacturing facility, including its technologies and infrastructure, through a virtual tour.

  2. Bio4C ProcessPad™ Product Overview 5/19/2020

    Introducing Bio4C ProcessPad™ Software, part of the BioContinuum™ Platform.

  3. Mastering The Art Of Developing A Successful Bispecific Antibody 10/3/2024

    Learn innovative strategies to overcome the complexities of bispecific antibody development, from intelligent design to efficient purification techniques.

  4. GMP-Focused Platform Processes For Microbial, pDNA, And mRNA 3/25/2025

    Mario Kraft, Director of Process Development at AGC Biologics' Heidelberg facility, explains how platform processes optimize microbial, plasmid DNA, and mRNA production.

  5. Early Preclinical Development: A Successful Transition To cGMP Manufacturing 12/2/2024

    Explore the development steps that lead to an mRNA construct optimized for your requirements and that meets future-proof cGMP manufacturing requirements, thereby de-risking the development.

  6. Explore What's Next: Product Characterization 7/17/2019

    Newer, high-resolution analytical techniques help answer questions regarding product heterogeneity and drug functions, and help assess for product-related aggregates and impurities.

  7. Virus Filtration In Continuous Processing: Novel Approaches For Optimal Performance 9/23/2024

    Watch to explore two novel approaches that have been developed to overcome the limitation of a filter's viral retention performance in continuous processes.

  8. Advancing Viral Vector Manufacturing: The Importance Of The Cell Line 9/16/2024

    Explore the pivotal role of cell lines in viral vector manufacturing, a complex, multi-step process that has traditionally been both time-consuming and labor-intensive.

  9. A Rapid, Innovative Approach To Release Testing 12/12/2022

    Innovative molecular methods will allow mAbs manufacturers to deliver critical therapeutic agents to patients faster. Learn about a powerful tool that accelerates bulk harvest testing.

  10. Biotherapy Characterization: Cell-Based Assays 7/17/2019

    MilliporeSigma Senior Scientist Agata Burzawa, MSc, explains how we can provide you with rich data sets to help you understand your complex biotherapy faster. Using limited volumes of samples for testing, our scientists employ leading technologies that integrate cytokine release monitoring with immunophenotyping of cells within the same sample.